Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoprevention Trial Using Erlotinib in Barrett's Esophagus With High-Grade Dysplasia

NCT00566800 is registered in ClinicalTrials.gov with Kansas City Veteran Affairs Medical Center as lead sponsor.

NCT NCT00566800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00566800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoprevention Trial Using Erlotinib in Barrett's Esophagus With High-Grade Dysplasia
Lead sponsor
Kansas City Veteran Affairs Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2007
Completion date
Not reported
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, precancerous condition